QGEN
Qiagen NV
Price:  
45.96 
USD
Volume:  
613,864.00
Netherlands | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

QGEN EV/EBITDA

22.7%
Upside

As of 2024-12-13, the EV/EBITDA ratio of Qiagen NV (QGEN) is 16.63. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. QGEN's latest enterprise value is 11,161.93 mil USD. QGEN's TTM EBITDA according to its financial statements is 671.07 mil USD. Dividing these 2 quantities gives us the above QGEN EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 18.8x - 20.6x 20.4x
Forward P/E multiples 19.0x - 21.6x 20.4x
Fair Price 51.51 - 59.33 56.39
Upside 12.1% - 29.1% 22.7%
45.96 USD
Stock Price
56.39 USD
Fair Price

QGEN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-10 16.67
2024-12-09 16.09
2024-12-06 15.79
2024-12-05 15.80
2024-12-04 15.91
2024-12-03 15.75
2024-12-02 15.87
2024-11-29 15.80
2024-11-27 15.90
2024-11-26 15.73
2024-11-25 15.74
2024-11-22 15.58
2024-11-21 15.43
2024-11-20 15.35
2024-11-19 14.92
2024-11-18 14.99
2024-11-15 15.08
2024-11-14 15.35
2024-11-13 15.53
2024-11-12 15.73
2024-11-11 16.00
2024-11-08 15.90
2024-11-07 16.03
2024-11-06 15.94
2024-11-05 15.97
2024-11-04 15.87
2024-11-01 15.68
2024-10-31 15.35
2024-10-30 15.40
2024-10-29 15.27
2024-10-28 15.26
2024-10-25 15.17
2024-10-24 15.19
2024-10-23 15.36
2024-10-22 15.39
2024-10-21 15.36
2024-10-18 15.65
2024-10-17 15.55
2024-10-16 15.72
2024-10-15 15.94
2024-10-14 16.01
2024-10-11 15.96
2024-10-10 15.75
2024-10-09 16.13
2024-10-08 15.84
2024-10-07 15.76
2024-10-04 15.84
2024-10-03 15.83
2024-10-02 16.10
2024-10-01 16.29